BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

Go back to BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
Techne Corp (NASDAQ: TECH) Delayed: 72.39 --0 (-0%)
Previous Close $72.39    52 Week High $117.42 
Open $72.39    52 Week Low $79.95 
Day High $72.39    P/E 23.43 
Day Low $72.39    EPS $3.09 
Volume 6,233